Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 3 completed trials

    Completion Rate
    100%(3/3)
    Active Trials
    0(0%)
    Results Posted
    100%(3 trials)

    Phase Distribution

    Phase 2/3
    2
    67%
    Phase 3
    1
    33%

    Phase Distribution

    0

    Early Stage

    2

    Mid Stage

    1

    Late Stage

    Phase Distribution3 total trials
    Phase 2/3Combined phases
    2(66.7%)
    Phase 3Large-scale testing
    1(33.3%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    100.0%

    3 of 3 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(3)

    Detailed Status

    Completed3

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2/3

    Trials by Phase

    Phase 2/32 (66.7%)
    Phase 31 (33.3%)

    Trials by Status

    completed3100%

    Recent Activity

    0 active trials
    Showing 3 of 3
    completedphase_3

    Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence

    NCT03353740
    completedphase_2_3

    Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients

    NCT02919111
    completedphase_2_3

    Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

    NCT02918357

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT03353740Phase 3

    Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence

    Completed
    NCT02919111Phase 2/3

    Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients

    Completed
    NCT02918357Phase 2/3

    Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3